Alkami director granted 457 deferred shares
Linville Judson C reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Linville Judson C reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Judson C. Linville reported receiving a grant of 457 shares of common stock as compensation, at a stated price of $0.00 per share. After this award, he directly holds 20,780 shares. According to the disclosure, he elected to defer receipt of these shares under the company’s 2021 Incentive Award Plan, making this a structured, plan-based equity grant rather than an open-market transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 457 | $0.00 | $0.00 |
Footnotes (1)
- F1. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Award Plan.
Key Figures
Key Terms
Form 4 regulatory
Grant, award, or other acquisition financial
2021 Incentive Award Plan financial
defer receipt financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALKT director Judson C. Linville report?
Does this ALKT Form 4 show any insider selling activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.